National Health Investors (NHI) Downgraded by Zacks Investment Research

Zacks Investment Research downgraded shares of National Health Investors (NYSE:NHI) from a hold rating to a sell rating in a research report sent to investors on Tuesday morning.

According to Zacks, “National Health Investors, Inc. is a real estate investment trust which invests in income producing health care properties primarily in the long-term care industry. The company provides current income for distribution to stockholders through investments in health care related facilities, including long-term care facilities, acute care hospitals, medical office buildings, retirement centers and assisted living facilities. “

A number of other brokerages also recently weighed in on NHI. ValuEngine raised shares of National Health Investors from a hold rating to a buy rating in a research note on Tuesday, December 11th. BMO Capital Markets downgraded shares of National Health Investors from a market perform rating to an underperform rating and set a $78.00 target price for the company. in a research note on Wednesday, February 20th. KeyCorp set a $65.00 price target on shares of National Health Investors and gave the stock a sell rating in a research report on Thursday, December 20th. Finally, SunTrust Banks lifted their price target on shares of National Health Investors to $85.00 and gave the stock a neutral rating in a research report on Wednesday, February 20th. They noted that the move was a valuation call. Three investment analysts have rated the stock with a sell rating, three have issued a hold rating and three have given a buy rating to the stock. National Health Investors presently has a consensus rating of Hold and an average price target of $78.14.

Shares of NYSE NHI opened at $79.24 on Tuesday. National Health Investors has a 1-year low of $65.10 and a 1-year high of $84.57. The stock has a market capitalization of $3.37 billion, a price-to-earnings ratio of 14.46 and a beta of 0.51. The company has a quick ratio of 17.92, a current ratio of 17.92 and a debt-to-equity ratio of 0.92.

National Health Investors (NYSE:NHI) last announced its earnings results on Tuesday, February 19th. The real estate investment trust reported $0.87 earnings per share for the quarter, missing the Zacks’ consensus estimate of $1.39 by ($0.52). National Health Investors had a return on equity of 11.36% and a net margin of 52.38%. The company had revenue of $74.00 million during the quarter, compared to the consensus estimate of $75.16 million. During the same period in the prior year, the firm posted $1.35 earnings per share. The company’s revenue was up 4.1% on a year-over-year basis. On average, equities research analysts anticipate that National Health Investors will post 5.5 earnings per share for the current year.

The firm also recently declared a quarterly dividend, which will be paid on Friday, May 10th. Stockholders of record on Friday, March 29th will be given a dividend of $1.05 per share. This is a boost from National Health Investors’s previous quarterly dividend of $1.00. The ex-dividend date is Thursday, March 28th. This represents a $4.20 annualized dividend and a dividend yield of 5.30%. National Health Investors’s payout ratio is currently 72.99%.

In other news, Director Robert A. Mccabe, Jr. sold 1,181 shares of National Health Investors stock in a transaction that occurred on Thursday, February 21st. The shares were sold at an average price of $78.04, for a total transaction of $92,165.24. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. 5.63% of the stock is owned by insiders.

Large investors have recently modified their holdings of the company. Russell Investments Group Ltd. grew its holdings in National Health Investors by 16.3% during the third quarter. Russell Investments Group Ltd. now owns 33,606 shares of the real estate investment trust’s stock valued at $2,540,000 after purchasing an additional 4,710 shares during the period. Wells Fargo & Company MN grew its holdings in National Health Investors by 1.8% during the third quarter. Wells Fargo & Company MN now owns 152,385 shares of the real estate investment trust’s stock valued at $11,519,000 after purchasing an additional 2,721 shares during the period. Meeder Asset Management Inc. grew its holdings in National Health Investors by 1,298.1% during the third quarter. Meeder Asset Management Inc. now owns 3,020 shares of the real estate investment trust’s stock valued at $228,000 after purchasing an additional 2,804 shares during the period. Cambridge Investment Research Advisors Inc. grew its holdings in National Health Investors by 23.3% during the third quarter. Cambridge Investment Research Advisors Inc. now owns 7,390 shares of the real estate investment trust’s stock valued at $559,000 after purchasing an additional 1,395 shares during the period. Finally, American Century Companies Inc. acquired a new position in National Health Investors during the third quarter valued at approximately $5,651,000. Institutional investors own 70.77% of the company’s stock.

About National Health Investors

Incorporated in 1991, National Health Investors, Inc (NYSE: NHI) is a real estate investment trust specializing in sale-leaseback, joint-venture, mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent, assisted and memory care communities, entrance-fee retirement communities, skilled nursing facilities, medical office buildings and specialty hospitals.

Read More: How can you know how many shares are floating?

Get a free copy of the Zacks research report on National Health Investors (NHI)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Analyst Recommendations for National Health Investors (NYSE:NHI)

Receive News & Ratings for National Health Investors Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National Health Investors and related companies with MarketBeat.com's FREE daily email newsletter.